首页> 美国卫生研究院文献>Journal of Clinical Laboratory Analysis >Identification of the four most common β‐globin gene mutations in Greek β‐thalassemic patients and carriers by PCR‐SSCP: advantages and limitations of the method
【2h】

Identification of the four most common β‐globin gene mutations in Greek β‐thalassemic patients and carriers by PCR‐SSCP: advantages and limitations of the method

机译:通过PCR-SSCP鉴定希腊β-地中海贫血患者和携带者中四种最常见的β-珠蛋白基因突变:方法的优势和局限性

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

In the present study we investigated whether the single‐strand conformational polymorphism (SSCP) method could be employed to identify (rather than simply detect) the four most common β‐globin gene mutations in the Greek population: IVS‐I‐110, Cd39, IVS‐I‐1, and IVS‐I‐6. Using DNA from 50 β‐thalassemic patients and carriers, we amplified by PCR the appropriate 238‐bp region of the human β‐globin gene, analyzed the reaction products by nondenaturing polyacrylamide gel electrophoresis, and visualized the bands by silver staining. Single‐stranded DNA (ssDNA) fragments showed a reproducible pattern of bands that was characteristic of the mutations present. With the use of control samples containing six of the 10 possible combinations of the four most common β‐globin gene mutations, we were able to predict the mutations present in a quarter of the patients studied. Our predictions were confirmed independently by the amplification refractory mutation system (ARMS) method. We conclude that this non‐radioactive PCR‐SSCP method can be used to reliably identify mutations in patients, provided that suitable controls are available. Moreover, the method is easy to apply to the identification of mutations in carriers, which makes it particularly useful for population screening. J. Clin. Lab. Anal. 20:1–7, 2006. © 2006 Wiley‐Liss, Inc.
机译:在本研究中,我们调查了单链构象多态性(SSCP)方法是否可用于识别(而不是简单地检测)希腊人口中最常见的四个β-珠蛋白基因突变:IVS-I-110,Cd39, IVS-I-1和IVS-I-6。我们使用来自50位β地中海贫血患者和携带者的DNA,通过PCR扩增了人类β珠蛋白基因的238bp适当区域,通过非变性聚丙烯酰胺凝胶电泳分析了反应产物,并通过银染可视化了条带。单链DNA(ssDNA)片段显示出可再现的条带模式,这是存在突变的特征。通过使用包含四种最常见的β-珠蛋白基因突变的10种可能组合中的6种的对照样品,我们能够预测所研究患者中四分之一的突变。我们的预测是通过扩增难治性突变系统(ARMS)方法独立确认的。我们得出的结论是,只要有合适的对照,这种非放射性PCR-SSCP方法可用于可靠地鉴定患者中的突变。而且,该方法易于应用于携带者突变的鉴定,这使其特别适用于人群筛选。 J.临床实验室肛门2006年12月1日至7日。©2006 Wiley-Liss,Inc.

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号